Skip to main content
Sign In

Christopher Hoyte, MD

​University of Colorado School of Medicine

Associate Professor of Emergency Medicine


Contact information

Anschutz Medical Campus
Leprino Building, Campus Box B215
12401 East 17th Avenue

Aurora, CO 80045

Dr. Christopher Hoyte's academic areas of interest are in education and research. He is interested in toxicology fellow and emergency medicine resident education. Dr. Hoyte's research interest is in the toxicologic effects of performance enhancing drugs and the role of medications on mitochondrial function and human athletic performance.
Degree Year ​Focus
Princeton University, Princeton, NJ B.S. 2000 ​Molecular Biology
The University of Medicine and Dentistry of New Jersey, Newark, NJ M.D. 2005 Doctor of Medicine
Cook County Hospital, Chicago, IL
Emergency Medicine Residency

Funded Projects


Other Projects

  • Pharmaceutical medications and their effect on athletic performance enhancement
  • The effect of medications associated with QT interval prolongation and sudden cardiac death in athletes
View All PubMed Publications

Selected Publications (5 out of 5)

  • Hoyte CO, Cushing TA, Heard KJ. Anaphylaxis to black widow spider antivenom. Am J Emerg Med. 2012 Jun;30(5):836.e1-2. doi: 10.1016/j.ajem.2011.03.017. PubMed PMID: 21641165.


  • Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012 Oct;60(4):435-8. doi: 10.1016/j.annemergmed.2012.03.007. Epub 2012 May 9. PubMed PMID: 22575211.

  • Hoyte CO, Leikin JB. Management of diethylene glycol ingestion. Clin Toxicol (Phila). 2012 Jul;50(6):525-7. doi: 10.3109/15563650.2012.696199. Epub 2012 Jun 14. PubMed PMID: 22694101


  • Hoyte CO, Albert D, Heard KJ. The use of energy drinks, dietary supplements, and prescription medications by United States college students to enhance athletic performance. J Community Health. 2013 Jun;38(3):575-80. doi: 10.1007/s10900-013-9653-5. PubMed PMID: 23371823.


  • Monte AA, Bronstein AC, Cao DJ, Heard KJ, Hoppe JA, Hoyte CO, Iwanicki JL, Lavonas EJ. An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med. 2014 Jan 23;370(4):389-90. doi: 10.1056/NEJMc1313655. PubMed PMID: 24450915; PubMed Central PMCID: PMC3983965.
  • ​Extraordinary Service Award, University of Colorado Hospital, December 2013
  • Student Teaching Award, University of Colorado, Foundations on Doctoring, 2013